BG Medicine said this week that is compliant with requirements for listing on the Nasdaq Capital Market.
BG requested transfer to the Capital Market in January after failing to meet the $50 million market value of listed securities requirement for listing on the Global Market. The Capital Market requires a company maintain $35 million market value or $2.5 million in stockholders equity.
As of its transfer request, the company was not compliant with the Capital Market requirements, either. However, it has since achieved compliance.